• Application Note

Methoxyverapamil

Methoxyverapamil
  • Waters Corporation
Download PDF Download PDF
Verapamil calcium channel blocker drug molecule structure

This is an Application Brief and does not contain a detailed Experimental section.

Abstract

This application note details on the analysis of methoxyverapamil using XTerra RP18 Columns.

Introduction

The compound analyzed in this study is methoxyverapamil. 

Methoxyverapamil

Experimental

Conditions

Column:

XTerra RP18 4.6 x 150 mm, 5 µm

Part number:

186000492

Mobile phase:

pH 3.0: H2O/ACN/100 mM NH4COOH, pH 3.0 30:60:10

pH 7.0: H2O/ACN/100 mM NH4HCO3, pH 7.0 40:50:10

pH 10.0 H2O/ACN/100 mM NH4HCO3, pH 10.0 28:62:10

Flow rate:

1.0 mL/min

Injection volume:

5 µL of 250 µg/mL

Temperature:

30 °C

Detection:

UV @ 270 nm

Instrument:

Alliance 2695, 2996 PDA

Mobile Phase pH

USP Tailing

3.0

1.25

7.0

1.11

10.0

1.1

Results and Discussion

Results

Featured Products

WA20738.066, June 2002

Back To Top Back To Top